Technology evaluation: WX-G250, Wilex/Ludwig Institute for Cancer Research

被引：0
|
作者：
Kennett, RH [1 ]
机构：
[1] Wheaton Coll, Dept Biol, Wheaton, IL 60187 USA
来源：
CURRENT OPINION IN MOLECULAR THERAPEUTICS | 2003年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Wilex AG, in collaboration with the Ludurig Institute for Cancer Research, is developing WX-G250, a alight chain chimeric antibody derived from the variable region of the mouse monoclonal antibody 6250, far the potential treatment of biliary cancer and renal cell carcinoma (RCC). The antibody is currently undergoing phase 11 clinical trials for RCC and preclinical development for biliary cancer.
引用
收藏
页码：70 / 75
页数：6
相关论文
共 30 条
  • [1] Wilex and Ludwig Institute to collaborate on clinical development of G250
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 1999, 12 (08) : 509 - 509
  • [2] THE-LUDWIG-INSTITUTE-FOR-CANCER-RESEARCH
    BAKER, CG
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1982, 7 (02) : 44 - 46
  • [3] A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma
    Bleumer, I
    Oosterwijk, E
    Oosterwijk-Wakka, JC
    Völler, MCW
    Melchior, S
    Warnaar, SO
    Mala, C
    Beck, J
    Mulders, PFA
    [J]. JOURNAL OF UROLOGY, 2006, 175 (01): : 57 - 62
  • [4] Ludwig Institute for Cancer Research - The first 25 years - Cover legend
    Weinhouse, S
    [J]. CANCER RESEARCH, 1997, 57 (20) : U12 - U12
  • [5] The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line Panel
    Behren, Andreas
    Anaka, Matthew
    Lo, Pu-Han
    Vella, Laura J.
    Davis, Ian D.
    Catimel, Jenny
    Cardwell, Tracy
    Gedye, Craig
    Hudson, Christopher
    Stan, Rodica
    Cebon, Jonathan
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2013, 26 (04) : 597 - 600
  • [6] A phase I/II trial with chimeric monoclonal antibody WX-G250 in combination with low-dose interleukin-2 for patients with metastatic renal cell carcinoma
    Bleumer, I
    Oosterwijk, E
    Beck, J
    Mala, C
    Ullrich, S
    Mulders, P
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 261 - 261
  • [7] An evaluation of the research experiences for undergraduates program at the Georgia Institute of Technology
    May, GS
    [J]. FRONTIERS IN EDUCATION 1997 - 27TH ANNUAL CONFERENCE, PROCEEDINGS, BOLS I - III, 1997, : 1132 - 1136
  • [8] The Institute of Cancer Research grant license to Oxford Gene Technology
    O'Hare, Alice
    [J]. BIOANALYSIS, 2013, 5 (10) : 1154 - 1154
  • [9] Technology evaluation: Canvaxin, John Wayne Cancer Institute/CancerVax
    Motl, SE
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (01) : 104 - 111
  • [10] National Cancer Institute establishes network of Clinical Proteomic Technology Centers for cancer research
    不详
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (08) : 443 - 443
123